Le Lézard
Classified in: Health
Subjects: PER, MAT

Dr. Kathryn Alcarez Joins The Exclusive Haute Beauty Network Representing The Medspa Category


NEW YORK, Oct. 22, 2020 /PRNewswire-PRWeb/ -- Dr. Kathryn Alcarez is a Manhattan-based, Internal Medicine Physician and has a combined 14 years of experience and specialized training in Aesthetic Medicine, Obesity Medicine, and Preventative Medicine. She is the founder and Medical Director of Aesthete Medical Wellness and Medspa.

Dr. Alcarez received her medical degree at the University of New England College of Osteopathic Medicine in Maine and completed her residency in Internal Medicine at Lenox Hill Hospital. She is affiliated with Mount Sinai Beth Israel and NYU Langone Medical Center.

Using a holistic and evidence-based approach to medicine, Dr. Alcarez seeks to ensure that her patients receive the best medical care to maintain long-term health and wellness. She considers physical, mental, and aesthetic health as integral to patients' overall wellbeing. For this reason, Dr. Alcarez offers comprehensive aesthetic consultations that include botox for medical purposes like migraines and hyperhidrosis, botox and fillers for anti-aging, radiofrequency skin tightening (Inmode Optimas), and radiofrequency body contouring (Inmode Contoura and Cutera's Trusculpt ID offered at the downtown location).

Learn more about Dr. Kathryn Alcarez by visiting: https://hauteliving.com/hautebeauty/member/dr-kathryn-alcarez/

ABOUT HAUTE BEAUTY NETWORK:

Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors.

For more about Haute Beauty, visit https://hauteliving.com/hautebeauty/

 

SOURCE Haute Beauty by Haute Living


These press releases may also interest you

at 22:03
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...

at 21:30
Greenbrook TMS Inc. ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this news release are in United States dollars, unless otherwise stated....

at 20:25
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...

at 20:12
BCACC is pleased to announce that its Deputy Registrar, Kathy Lauriente, has been honoured with the Distinguished Service Award from Thompson Rivers University. The award recognizes stellar contributions to the University, community, and the public...

at 19:29
Suffolk DBT is proud to announce the completion of their initial expansion to accommodate the growing need for DBT therapy...

at 18:24
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference. On April 26, 2024, the hearing will commence 11:15 a.m. Members of the public may observe the hearing by videoconference, by...



News published on and distributed by: